US Dementia Diagnoses to Reach One Million Annually by 2060
Projections show case counts doubling in four decades while staffing shortages and funding cuts strain the care system.
By Noor Phillips ·
The aging of the American population is set to place new demands on a medical system that experts describe as already under pressure. A recent analysis projects that the number of adults diagnosed with dementia in the United States will double within the next three decades.
Researchers published a study in JAMA Neurology estimating that global new dementia cases will increase from 11.4 million in 2023 to 24.7 million in 2050. A separate 2024 JAMA study specific to the US projected that annual diagnoses will grow from 514,000 in 2020 to 1 million by 2060. These figures reflect a steady rise driven by demographic shifts rather than a sudden change in disease prevalence.
Longer life expectancy is the primary driver of this increase. More people are surviving into the age ranges where dementia is most common. The growth of the Hispanic population in the US is another factor. That group nearly doubled between 2000 and 2024. The Alzheimer's Association states that Hispanic people are 1.5 times as likely as white people to develop dementia. Jordan Weiss, an assistant professor at the Optimal Aging Institute at NYU Langone, noted that even with risk reduction, the sheer number of adults entering high-risk age groups will drive case counts up.
The workforce tasked with caring for these patients is already thin. A 2024 report from the American Health Care Association found that almost all facilities struggled to recruit staff. Two-thirds of these facilities cited a lack of interested or qualified candidates as a primary issue. About half of the facilities reported limiting new admissions due to these staffing gaps.
Demand for direct care workers is rising faster than supply. The Center for American Progress projects that demand for nursing assistants and home health aides will rise by 48% and 42% respectively between 2020 and 2035. However, the Bureau of Labor Statistics reported that the median wage for these roles was under $19 an hour in May 2025. Regina Shih, a professor of epidemiology at Emory University, said retention is low because the work is difficult and cannot be replaced with AI. The supply of geriatric doctors has also declined. A JAMA report found the US had 10,270 geriatricians in 2000 but only 7,413 in 2022. Weiss said compensation is part of the reason for this decline.
States are attempting to address these gaps through financial incentives. A KFF survey found that almost half of states offered incentive payments in 2025 to recruit or retain Medicaid home care workers. South Carolina created a loan forgiveness program for physicians who complete geriatrics fellowships and practice in the state for at least five years. These efforts occur alongside the One Big Beautiful Bill Act, passed in 2025, which included nearly $1 trillion in Medicaid cuts over 10 years. KFF reports that Medicaid pays for more than half of US long-term care spending.
Medical advances offer some tools for management and diagnosis. The Food and Drug Administration has approved two drugs, Kisunla and Leqembi, that can modestly slow cognitive decline in some patients with early Alzheimer's disease. Blood tests are also available to help diagnose the illness and potentially predict who may develop it. Julie Zissimopoulos, a University of Southern California professor, said these advances may improve lives but will be costly for the healthcare system. Weiss urged against waiting for a cure, stating there is a real opportunity to lower risk through better cardiovascular health and physical activity.
